Regeneron Pharmaceuticals, Inc. REGN

NAS: REGN | ISIN: US75886F1075   10/04/2026
748,87 USD (-2,47%)
(-2,47%)   10/04/2026
Grafiek Regeneron Pharmaceuticals, Inc. Grafiek Regeneron Pharmaceuticals, Inc.
woensdag 29 april 2026, 12:30
Kwartaalcijfers (1ste kwartaal)

Regeneron Pharmaceuticals, Inc. in het nieuws

3 april 2026 · TriNetX collabore avec Regeneron pour accéder aux dossiers médicaux électroniques dépersonnalisés de 300 millions de patients afin de stimuler la recherche et le développement de produits dans le domaine des sciences de la vie et des solutions de santé numérique · Persbericht

2 april 2026 · TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions · Persbericht

12 maart 2025 · Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem · Persbericht

6 maart 2025 · Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

5 maart 2025 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals · Persbericht

5 maart 2025 · CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Regeneron Pharmaceuticals (NASDAQ: REGN) Investors to Inquire About a Securities Fraud Class Action by March 10, 2025 · Persbericht

4 maart 2025 · Contact Levi & Korsinsky by March 10, 2025 Deadline to Join Class Action Against Regeneron Pharmaceuticals, Inc.(REGN) · Persbericht

29 mei 2024 · Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors · Persbericht

13 maart 2024 · High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization · Persbericht

24 januari 2024 · Top 40 High School Scientists in Prestigious Regeneron Science Talent Search to Compete for $1.8 Million in Awards · Persbericht

Profiel Regeneron Pharmaceuticals, Inc.

Biotechnologie
Fabricage van farmaceutische preparaten
Gezondheidstechnologie
Productie

Website: www.regeneron.com

Hoofdzetel: Tarrytown, New York vlag Verenigde Staten

Mijn selecties